Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2023Journal of Clinical OncologyOpen Access

Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study

View Full Paper
Ask AI
Bookmark
Share

Authors

JVJurjen VersluisErasmus MCWSWael SaberMedical College of WisconsinHTHarrison TsaiBrigham and Women's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Versluis et al. (2023) studied this question.

synapsesocial.com/papers/69d80a6bfc5937d393ae2bbdhttps://doi.org/10.1200/jco.23.00866
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant Data1974 · 441 citations
  2. 2TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes2016 · 802 citations
  3. 3Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms2020 · 30 citations
  4. 4Molecular International Prognostic Scoring System for Myelodysplastic Syndromes2022 · 867 citations
  5. 5Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes2022 · 144 citations